These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 18413762)

  • 81. Boc-lysinated-betulonic acid: a potent, anti-prostate cancer agent.
    Saxena BB; Zhu L; Hao M; Kisilis E; Katdare M; Oktem O; Bomshteyn A; Rathnam P
    Bioorg Med Chem; 2006 Sep; 14(18):6349-58. PubMed ID: 16777417
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cytoprotection of human endothelial cells against oxidative stress by 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im): application of systems biology to understand the mechanism of action.
    Wang X; Bynum JA; Stavchansky S; Bowman PD
    Eur J Pharmacol; 2014 Jul; 734():122-31. PubMed ID: 24703885
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice.
    Wang YY; Zhang CY; Ma YQ; He ZX; Zhe H; Zhou SF
    Drug Des Devel Ther; 2015; 9():3163-78. PubMed ID: 26124639
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis.
    Yuan-Jing F; Nan-Shan H; Lian X
    Cancer Lett; 2009 Nov; 284(2):189-97. PubMed ID: 19433345
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance.
    Chauhan D; Li G; Podar K; Hideshima T; Shringarpure R; Catley L; Mitsiades C; Munshi N; Tai YT; Suh N; Gribble GW; Honda T; Schlossman R; Richardson P; Sporn MB; Anderson KC
    Blood; 2004 Apr; 103(8):3158-66. PubMed ID: 15070698
    [TBL] [Abstract][Full Text] [Related]  

  • 86. CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms.
    Han SS; Peng L; Chung ST; DuBois W; Maeng SH; Shaffer AL; Sporn MB; Janz S
    Mol Cancer; 2006 Jun; 5():22. PubMed ID: 16759389
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention.
    Cao M; Onyango EO; Williams CR; Royce DB; Gribble GW; Sporn MB; Liby KT
    Pharmacol Res; 2015 Oct; 100():135-47. PubMed ID: 26238177
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
    Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M
    Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T
    Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
    Ji Y; Lee HJ; Goodman C; Uskokovic M; Liby K; Sporn M; Suh N
    Mol Cancer Ther; 2006 Jun; 5(6):1452-8. PubMed ID: 16818503
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity.
    Huh J; Liepins A; Zielonka J; Andrekopoulos C; Kalyanaraman B; Sorokin A
    Cancer Res; 2006 Apr; 66(7):3726-36. PubMed ID: 16585199
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Human neuroblastoma cells rapidly enter cell cycle arrest and apoptosis following exposure to C-28 derivatives of the synthetic triterpenoid CDDO.
    Alabran JL; Cheuk A; Liby K; Sporn M; Khan J; Letterio J; Leskov KS
    Cancer Biol Ther; 2008 May; 7(5):709-17. PubMed ID: 18277094
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways.
    Angelucci A; Valentini A; Millimaggi D; Gravina GL; Miano R; Dolo V; Vicentini C; Bologna M; Federici G; Bernardini S
    Anticancer Drugs; 2006 Nov; 17(10):1141-50. PubMed ID: 17075313
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Involvement of both extrinsic and intrinsic apoptotic pathways in apoptosis induced by genistein in human cervical cancer cells.
    Kim SH; Kim SH; Lee SC; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():196-201. PubMed ID: 19723056
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Ca2+ influx-mediated dilation of the endoplasmic reticulum and c-FLIPL downregulation trigger CDDO-Me-induced apoptosis in breast cancer cells.
    Jeong SA; Kim IY; Lee AR; Yoon MJ; Cho H; Lee JS; Choi KS
    Oncotarget; 2015 Aug; 6(25):21173-92. PubMed ID: 26053096
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism.
    Deeb D; Gao X; Jiang H; Janic B; Arbab AS; Rojanasakul Y; Dulchavsky SA; Gautam SC
    Biochem Pharmacol; 2010 Feb; 79(3):350-60. PubMed ID: 19782051
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling.
    Deeb D; Gao X; Liu Y; Jiang D; Divine GW; Arbab AS; Dulchavsky SA; Gautam SC
    Carcinogenesis; 2011 May; 32(5):757-64. PubMed ID: 21325633
    [TBL] [Abstract][Full Text] [Related]  

  • 98. CDDO-imidazolide induces DNA damage, G2/M arrest and apoptosis in BRCA1-mutated breast cancer cells.
    Kim EH; Deng CX; Sporn MB; Liby KT
    Cancer Prev Res (Phila); 2011 Mar; 4(3):425-34. PubMed ID: 21372041
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr(db/db) mice.
    Saha PK; Reddy VT; Konopleva M; Andreeff M; Chan L
    J Biol Chem; 2010 Dec; 285(52):40581-92. PubMed ID: 20956520
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Inhibition of Lon protease by triterpenoids alters mitochondria and is associated to cell death in human cancer cells.
    Gibellini L; Pinti M; Bartolomeo R; De Biasi S; Cormio A; Musicco C; Carnevale G; Pecorini S; Nasi M; De Pol A; Cossarizza A
    Oncotarget; 2015 Sep; 6(28):25466-83. PubMed ID: 26314956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.